Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02009917
Other study ID # H12-01683
Secondary ID
Status Completed
Phase N/A
First received December 9, 2013
Last updated July 13, 2017
Start date October 2013
Est. completion date April 2015

Study information

Verified date July 2017
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Protein is a major structural component of all cells in the body. The nutritional importance of protein is because of their amino acids. 9 are called essential and 11 are called non-essential, based on whether we need to get them from diet. This classification is based on studies done using older techniques. Recent studies suggest that these so called non-essential amino acids play important roles in our body's health. For the first time, this proposal defines an experimental design to examine non- essential amino acid/nitrogen requirements and metabolism in humans using the Indicator Amino Acid Oxidation (IAAO) technique.

The objective of the current study is to examine the application of IAAO technique to determine the non-essential amino acid/nitrogen requirement in adult humans.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date April 2015
Est. primary completion date January 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- 20-40 years of age

- Male

- Classified as normal body weight based on body mass index (BMI) 18.5-25kg/m2

- Free of any concurrent illness

Exclusion Criteria:

- Men not in good health or have a metabolic, neurological, genetic or immune disorder including diabetes and hypertension

- Men who are classified as underweight(<18.5kg/m2), overweight(25-30kg/m2) or obese (>30kg/m2) using the BMI classification)

- Men who are allergic to milk, eggs and egg protein

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Child and Family Research Institute Vancouver British Columbia

Sponsors (2)

Lead Sponsor Collaborator
University of British Columbia Ajinomoto Co., Inc.

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary 13 Carbon dioxide production Urine and breath samples will be collected to measure the rate of oxidation of expired breath and flux by enrichment of urine. 8 hours (1study day)
See also
  Status Clinical Trial Phase
Recruiting NCT05691660 - A Study of TAS3731 in Healthy Adults Phase 1
Completed NCT04887727 - Development of Oral Amino Acid Tracers to Study Protein Turnover in Humans N/A
Completed NCT05396235 - A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males Phase 1